Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Cash from Financing Activities (2021 - 2025)

Lucid Diagnostics' Cash from Financing Activities history spans 5 years, with the latest figure at $2000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 99.99% year-over-year to $2000.0; the TTM value through Dec 2025 reached $59.0 million, up 22.34%, while the annual FY2025 figure was $59.0 million, 22.34% up from the prior year.
  • Cash from Financing Activities reached $2000.0 in Q4 2025 per LUCD's latest filing, down from $27.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $64.3 million in Q4 2021 to a low of $1000.0 in Q4 2022.
  • Average Cash from Financing Activities over 5 years is $11.7 million, with a median of $4.7 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: plummeted 100.0% in 2022, then skyrocketed 499900.0% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $64.3 million in 2021, then tumbled by 100.0% to $1000.0 in 2022, then surged by 499900.0% to $5.0 million in 2023, then soared by 259.98% to $18.0 million in 2024, then crashed by 99.99% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Cash from Financing Activities are $2000.0 (Q4 2025), $27.1 million (Q3 2025), and $16.5 million (Q2 2025).